IP Library Granted Patent US 10,093,616
Granted Patent B2
US 10,093,616 · App. 15/238,665 · Granted Oct 9, 2018

Preparation of hydroxy-benzylbenzene derivatives

Inventors: Jacques Roberge (Princeton, NJ); Carine Vaxelaire (Shanghai, CN); Baohu Liu (Shanghai, CN); Ge Xu (Shanghai, CN); Jian Zhang (Shanghai, CN); Xinxing Tang (Shanghai, CN); Baihua Xu (Malden, MA)
Assignee: THERACOS SUB, LLC
C07C309/73C07C37/055C07C41/16C07C41/26C07C41/40C07C303/28C07C309/75C07B2200/05C07B2200/13C07C2601/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,093,616
App. No.
15/238,665
Granted
Oct 9, 2018
Kind
B2
Abstract

Methods for preparing intermediates of SGLT2 inhibitors are provided, including crystalline forms and methods of crystallizing intermediates.

Claims (21)

1. A method of preparing a compound of Formula III:

the method comprising:

(a) forming a first reaction mixture comprising Mg and a compound having the structure:

in tetrahydrofuran solvent, under conditions suitable to form an intermediate compound having the structure:

(b) contacting the first reaction mixture with water and 2-methyl-tetrahydrofuran such that the intermediate of step (a) is substantially dissolved in the 2-methyl-tetrahydrofuran; and

(c) forming a second reaction mixture comprising 4-methylbenzene-1-sulfonyl chloride (Tosyl-Cl) and the 2-methyl-tetrahydrofuran of step (b) containing the intermediate of step (a), under conditions suitable to form the compound of Formula III,

wherein the 2-methyl-tetrahydrofuran containing the intermediate of step (a) is used in step (c) without removing the 2-methyl-tetrahydrofuran to form a concentrated intermediate.

2. The method of claim 1 , wherein the compound of step (a) is

3. The method of claim 1 , wherein the first reaction mixture in step (a) further comprises I 2 .

4. The method of claim 1 , wherein the first reaction mixture in step (a) further comprises BrCH 2 CH 2 Br.

5. The method of claim 1 , wherein the first reaction mixture in step (a) further comprises BrCH 2 CH 2 Br and 12.

6. The method of claim 1 , wherein step (b) comprises contacting the first reaction mixture with water, an acid, and 2-methyl-tetrahydrofuran such that the intermediate of step (a) is substantially dissolved in the 2-methyl-tetrahydrofuran.

7. The method of claim 6 , wherein step (b) comprises contacting the first reaction mixture with water, an acid, sodium chloride and 2-methyl-tetrahydrofuran such that the intermediate of step (a) is substantially dissolved in the 2-methyl-tetrahydrofuran.

8. The method of claim 7 , wherein the acid is selected from the group consisting of hydrochloric acid, formic acid, acetic acid, citric acid, lactic acid, oxalic acid, and glycolic acid.

9. The method of claim 8 , wherein the acid is hydrochloric acid.

10. The method of claim 8 , wherein the acid is glycolic acid.

11. The method of claim 1 , wherein the second reaction mixture of step (c) further comprises tetrahydrofuran (THF).

12. The method of claim 1 , wherein the compound of Formula III is prepared in at least 50% yield.

13. The method of claim 12 , wherein the compound of Formula III is prepared in at least 65% yield.

14. The method of 1 , wherein at least about 75% of the intermediate of step (a) is dissolved in the 2-methyl-tetrahydrofuran in step (b).

15. The method of 1 , wherein at least about 90% of the intermediate of step (a) is dissolved in the 2-methyl-tetrahydrofuran in step (b).

Assignments (6)
CHANGE OF NAME Recorded Jan 10, 2023
From: THERACOS SUB, LLC
To: THERACOSBIO, LLC
Reel/Frame 062351/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: THERACOS, INC.
To: THERACOS SUB, LLC
Reel/Frame 041138/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: TANG, XINXING
To: PHARMARESOURCES (SHANGHAI) CO., LTD.
Reel/Frame 041138/0862 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: PHARMARESOURCES (SHANGHAI) CO., LTD.
To: EGRET PHARMA (SHANGHAI) LIMITED
Reel/Frame 041138/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: ROBERGE, JACQUES; VAXELAIRE, CARINE; LIU, BAOHU; XU, GE; ZHANG, JIAN
To: THERACOS, INC.
Reel/Frame 041138/0935 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: EGRET PHARMA (SHANGHAI) LIMITED
To: THERACOS, INC.
Reel/Frame 041138/0976 →
Priority Claims (1)
WO PCT/CN2013/001227 · Oct 12, 2013 · international
Continuity (2)
Division 14511725 · Oct 10, 2014
Related Publication 20160355471A1 · Dec 8, 2016
Cited By (1)
US 12,594,243